We’ve just launched a new portal to help you explore stocks, crypto, ETFs, and more data

REGN

547.66998 USD
13.26
2.36%
Last update May 8, 3:59 PM EDT
Market closed
Day range
520.5
552.57422
Previous close
560.92999
Open
547.88000
Access this stock data via API
Subscribe
Regeneron Pharmaceuticals, Inc.
547.67
13.26
2.36%

Financials

Income statement

Fiscal date Mar 2025 Dec 2024 Sep 2024 Jun 2024
Total reported revenue 3.0B 3.8B 3.7B 3.5B
Cost of revenue 464.3M 565.4M 491.1M 480.2M
Gross profit 2.6B 3.2B 3.2B 3.1B
Operating expense
Research & development 1.3B 1.4B 1.3B 1.2B
Selling general and admin 633M 792.2M 714.4M 758.8M
Other operating expenses 15.5M 8M 14.6M
Operating income 591.7M 990.2M 1.2B 1.1B
Non operating interest income
Income 173.5M 183.1M 187.4M 179.4M
Expense 8.7M 10.5M 13.8M 14.8M
Other income expense 148.5M -204.7M 139.9M 393.9M
Pretax income 905M 958.1M 1.5B 1.6B
Tax provision 96.3M 40.4M 152.4M 195.8M
Net income 808.7M 917.7M 1.3B 1.4B
Basic EPS 7.6 8.5 12.4 13.3
Diluted EPS 7.3 8.1 11.5 12.4
Basic average shares 106.7M 107.6M 108.1M 108.1M
Diluted average shares 111.2M 113.8M 116.2M 115.4M
EBITDA 900.9M 1.3B 1.5B 1.4B
Net income from continuing op. 808.7M 917.7M 1.3B 1.4B
Minority interests
Preferred stock dividends
Market closed

Exchange is currently closed
Pre-market opens in 7 hours 49 minutes

20:10
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).